Search Results - Wang-Gillam, Andrea

Entering the molecular era of gastrointestinal oncology: current updates and challenges by Wang-Gillam, Andrea, Lim, Kian-Huat

Get full text Get full text Get full text

Promising therapeutics of gastrointestinal cancers in clinical trials by Du, Lingling, Che, Zheng, Wang-Gillam, Andrea

Get full text Get full text Get full text

Advanced pancreatic adenocarcinoma: a review of current treatment strategies and developing therapies by Teague, Andrea, Lim, Kian-Huat, Wang-Gillam, Andrea

Get full text Get full text Get full text

Digital Ischemia and Necrosis: A Rarely Described Complication of Gemcitabine in Pancreatic Adenocarcinoma by So, Eiichiro, Crees, Zachary D., Crites, Danielle, Wang-Gillam, Andrea

Get full text Get full text Get full text

Nab-paclitaxel monotherapy in refractory pancreatic adenocarcinoma by Peddi, Parvin F., Cho, May, Wang, Jian, Gao, Feng, Wang-Gillam, Andrea

Get full text Get full text Get full text

Racial Disparities in the Outcomes of Patients With Stage IV Pancreatic Adenocarcinoma are Mediated by Chemotherapy Utilization by Atkins, Jordan J., Fiala, Mark A., Wang-Gillam, Andrea, Wildes, Tanya M.

Get full text Get full text Get full text

Chemotherapy-associated Posterior Reversible Encephalopathy Syndrome: A Case Report and Review of the Literature by How, Joan, Blattner, Margaret, Fowler, Susan, Wang-Gillam, Andrea, Schindler, Suzanne E

Get full text Get full text Get full text

Neoadjuvant Therapy of Pancreatic Cancer: The Emerging Paradigm? by Lim, Kian-Huat, Chung, Eugene, Khan, Adeel, Cao, Dengfeng, Linehan, David, Ben-Josef, Edgar, Wang-Gillam, Andrea

Get full text Get full text Get full text

Phase II Trial of Gemcitabine and Tanespimycin (17AAG) in Metastatic Pancreatic Cancer: A Mayo Clinic Phase II Consortium Study by Pedersen, Katrina S., Kim, George P., Foster, Nathan R., Wang-Gillam, Andrea, Erlichman, Charles, McWilliams, Robert R.

Get full text Get full text Get full text

Vitamin D deficiency and prognostics among patients with pancreatic adenocarcinoma by Cho, May, Peddi, Parvin F, Ding, Kevin, Chen, Ling, Thomas, Denise, Wang, Jian, Lockhart, Albert C, Tan, Benjamin, Wang-Gillam, Andrea

Get full text Get full text Get full text

Immunogenicity of influenza vaccination in patients with cancer by Waqar, Saiama N., Boehmer, Leigh, Morgensztern, Daniel, Wang-Gillam, Andrea, Sorscher, Steven, Lawrence, Steven, Gao, Feng, Guebert, Kalin, Williams, Kristina, Govindan, Ramaswamy

Get full text Get full text Get full text

Concurrent HER or PI3K Inhibition Potentiates the Anti-tumor Effect of ERK Inhibitor Ulixertinib in Preclinical Pancreatic Cancer Models by Jiang, Hongmei, Xu, Mai, Li, Lin, Grierson, Patrick, Dodhiawala, Paarth, Highkin, Maureen, Zhang, Daoxiang, Li, Qiong, Wang-Gillam, Andrea, Lim, Kian-Huat

Get full text Get full text Get full text

Tumor-Stroma IL-1β-IRAK4 Feedforward Circuitry Drives Tumor Fibrosis, Chemoresistance, And Poor Prognosis In Pancreatic Cancer by Zhang, Daoxiang, Li, Lin, Jiang, Hongmei, Li, Qiong, Wang-Gillam, Andrea, Yu, Jinsheng, Head, Richard, Liu, Jingxia, Ruzinova, Marianna B., Lim, Kian-Huat

Get full text Get full text Get full text

Metformin Downregulates PD-L1 Expression in Esophageal Squamous Cell Carcinoma by Inhibiting IL-6 Signaling Pathway by Lu, Yao, Xin, Dao, Guan, Lulu, Xu, Mengli, Yang, Yalan, Chen, Yu, Yang, Yuanyuan, Wang-Gillam, Andrea, Wang, Li, Zong, Shanggang, Wang, Feng

Get full text Get full text Get full text

Constitutive IRAK4 Activation Underlies Poor Prognosis and Chemoresistance In Pancreatic Ductal Adenocarcinoma by Zhang, Daoxiang, Li, Lin, Jiang, Hongmei, Knolhoff, Brett, Lockhart, Albert C., Wang-Gillam, Andrea, DeNardo, David G., Ruzinova, Marianna B., Lim, Kian-Huat

Get full text Get full text Get full text

Phase II trial of levocetirizine with capecitabine and bevacizumab to overcome the resistance of antiangiogenic therapies in refractory metastatic colorectal cancer by Amin, Manik, Desai, Monica, Trinkaus, Kathryn, Brown, Amberly, Wang-Gillam, Andrea, Tan, Benjamin, Picus, Joel, Sorscher, Steven, Highkin, Maureen, Lears, Kim, Lockhart, Albert C.

Get full text Get full text Get full text

A phase I study of subcutaneously administered aflibercept (VEGF trap) in a new formulation in patients with advanced solid tumors by Wang-Gillam, Andrea, Tew, William P., Rothenberg, Mace L., Dupont, Jakob, Cooper, Wendy, Sternas, Lars, Buzenet, Giliane, Sosman, Jeffrey A., Spriggs, David R., Lockhart, Albert Craig

Get full text Get full text Get full text

TPL2 enforces RAS-induced inflammatory signaling and is activated by point mutations by Dodhiawala, Paarth B., Khurana, Namrata, Zhang, Daoxiang, Cheng, Yi, Li, Lin, Wei, Qing, Seehra, Kuljeet, Jiang, Hongmei, Grierson, Patrick M., Wang-Gillam, Andrea, Lim, Kian-Huat

Get full text Get full text Get full text

Ablative Five-Fraction Stereotactic Body Radiation Therapy for Inoperable Pancreatic Cancer Using Online MR-Guided Adaptation by Hassanzadeh, Comron, Rudra, Soumon, Bommireddy, Ani, Hawkins, William G., Wang-Gillam, Andrea, Fields, Ryan C., Cai, Bin, Park, Justin, Green, Olga, Roach, Michael, Henke, Lauren, Kim, Hyun

Get full text Get full text Get full text

CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T Cell Checkpoint Immunotherapy in Pancreatic Cancer Models by Zhu, Yu, Knolhoff, Brett L., Meyer, Melissa A., Nywening, Timothy M., West, Brian L., Luo, Jingqin, Wang-Gillam, Andrea, Goedegebuure, S Peter, Linehan, David C., DeNardo, David G.

Get full text Get full text Get full text